Report Detail

Pharma & Healthcare Global Methotrexate Tablets Market Research Report 2022

  • RnM4438742
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 107 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Methotrexate Tablets Market Overview

    • 1.1 Product Overview and Scope of Methotrexate Tablets
    • 1.2 Methotrexate Tablets Segment by Type
      • 1.2.1 Global Methotrexate Tablets Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 2mg
      • 1.2.3 2.5mg
      • 1.2.4 10mg
      • 1.2.5 Others
    • 1.3 Methotrexate Tablets Segment by Application
      • 1.3.1 Global Methotrexate Tablets Sales Comparison by Application: (2022-2028)
      • 1.3.2 Cancers
      • 1.3.3 Rheumatoid Arthritis
      • 1.3.4 Others
    • 1.4 Global Methotrexate Tablets Market Size Estimates and Forecasts
      • 1.4.1 Global Methotrexate Tablets Revenue 2017-2028
      • 1.4.2 Global Methotrexate Tablets Sales 2017-2028
      • 1.4.3 Methotrexate Tablets Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Methotrexate Tablets Market Competition by Manufacturers

    • 2.1 Global Methotrexate Tablets Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Methotrexate Tablets Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Methotrexate Tablets Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Methotrexate Tablets Manufacturing Sites, Area Served, Product Type
    • 2.5 Methotrexate Tablets Market Competitive Situation and Trends
      • 2.5.1 Methotrexate Tablets Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Methotrexate Tablets Players Market Share by Revenue
      • 2.5.3 Global Methotrexate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Methotrexate Tablets Retrospective Market Scenario by Region

    • 3.1 Global Methotrexate Tablets Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Methotrexate Tablets Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Methotrexate Tablets Market Facts & Figures by Country
      • 3.3.1 North America Methotrexate Tablets Sales by Country
      • 3.3.2 North America Methotrexate Tablets Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Methotrexate Tablets Market Facts & Figures by Country
      • 3.4.1 Europe Methotrexate Tablets Sales by Country
      • 3.4.2 Europe Methotrexate Tablets Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Methotrexate Tablets Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Methotrexate Tablets Sales by Region
      • 3.5.2 Asia Pacific Methotrexate Tablets Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Methotrexate Tablets Market Facts & Figures by Country
      • 3.6.1 Latin America Methotrexate Tablets Sales by Country
      • 3.6.2 Latin America Methotrexate Tablets Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Methotrexate Tablets Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Methotrexate Tablets Sales by Country
      • 3.7.2 Middle East and Africa Methotrexate Tablets Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Methotrexate Tablets Historic Market Analysis by Type

    • 4.1 Global Methotrexate Tablets Sales Market Share by Type (2017-2022)
    • 4.2 Global Methotrexate Tablets Revenue Market Share by Type (2017-2022)
    • 4.3 Global Methotrexate Tablets Price by Type (2017-2022)

    5 Global Methotrexate Tablets Historic Market Analysis by Application

    • 5.1 Global Methotrexate Tablets Sales Market Share by Application (2017-2022)
    • 5.2 Global Methotrexate Tablets Revenue Market Share by Application (2017-2022)
    • 5.3 Global Methotrexate Tablets Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Accord Healthcare
      • 6.1.1 Accord Healthcare Corporation Information
      • 6.1.2 Accord Healthcare Description and Business Overview
      • 6.1.3 Accord Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Accord Healthcare Methotrexate Tablets Product Portfolio
      • 6.1.5 Accord Healthcare Recent Developments/Updates
    • 6.2 Cipla
      • 6.2.1 Cipla Corporation Information
      • 6.2.2 Cipla Description and Business Overview
      • 6.2.3 Cipla Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Cipla Methotrexate Tablets Product Portfolio
      • 6.2.5 Cipla Recent Developments/Updates
    • 6.3 Morningside Healthcare
      • 6.3.1 Morningside Healthcare Corporation Information
      • 6.3.2 Morningside Healthcare Description and Business Overview
      • 6.3.3 Morningside Healthcare Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Morningside Healthcare Methotrexate Tablets Product Portfolio
      • 6.3.5 Morningside Healthcare Recent Developments/Updates
    • 6.4 Ebewe Pharma
      • 6.4.1 Ebewe Pharma Corporation Information
      • 6.4.2 Ebewe Pharma Description and Business Overview
      • 6.4.3 Ebewe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Ebewe Pharma Methotrexate Tablets Product Portfolio
      • 6.4.5 Ebewe Pharma Recent Developments/Updates
    • 6.5 Orion
      • 6.5.1 Orion Corporation Information
      • 6.5.2 Orion Description and Business Overview
      • 6.5.3 Orion Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Orion Methotrexate Tablets Product Portfolio
      • 6.5.5 Orion Recent Developments/Updates
    • 6.6 Nihon Generic
      • 6.6.1 Nihon Generic Corporation Information
      • 6.6.2 Nihon Generic Description and Business Overview
      • 6.6.3 Nihon Generic Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Nihon Generic Methotrexate Tablets Product Portfolio
      • 6.6.5 Nihon Generic Recent Developments/Updates
    • 6.7 Nippon Zoki Pharmaceutical
      • 6.6.1 Nippon Zoki Pharmaceutical Corporation Information
      • 6.6.2 Nippon Zoki Pharmaceutical Description and Business Overview
      • 6.6.3 Nippon Zoki Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Nippon Zoki Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.7.5 Nippon Zoki Pharmaceutical Recent Developments/Updates
    • 6.8 Daito Pharmaceutical
      • 6.8.1 Daito Pharmaceutical Corporation Information
      • 6.8.2 Daito Pharmaceutical Description and Business Overview
      • 6.8.3 Daito Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Daito Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.8.5 Daito Pharmaceutical Recent Developments/Updates
    • 6.9 Nichi-Iko Pharmaceutical
      • 6.9.1 Nichi-Iko Pharmaceutical Corporation Information
      • 6.9.2 Nichi-Iko Pharmaceutical Description and Business Overview
      • 6.9.3 Nichi-Iko Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Nichi-Iko Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.9.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
    • 6.10 Towa Pharmaceutical
      • 6.10.1 Towa Pharmaceutical Corporation Information
      • 6.10.2 Towa Pharmaceutical Description and Business Overview
      • 6.10.3 Towa Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 Towa Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.10.5 Towa Pharmaceutical Recent Developments/Updates
    • 6.11 Mitsubishi Tanabe Pharma
      • 6.11.1 Mitsubishi Tanabe Pharma Corporation Information
      • 6.11.2 Mitsubishi Tanabe Pharma Methotrexate Tablets Description and Business Overview
      • 6.11.3 Mitsubishi Tanabe Pharma Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Mitsubishi Tanabe Pharma Methotrexate Tablets Product Portfolio
      • 6.11.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
    • 6.12 Ayumi Pharmaceutical
      • 6.12.1 Ayumi Pharmaceutical Corporation Information
      • 6.12.2 Ayumi Pharmaceutical Methotrexate Tablets Description and Business Overview
      • 6.12.3 Ayumi Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 Ayumi Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.12.5 Ayumi Pharmaceutical Recent Developments/Updates
    • 6.13 Sinomune Pharmaceutical
      • 6.13.1 Sinomune Pharmaceutical Corporation Information
      • 6.13.2 Sinomune Pharmaceutical Methotrexate Tablets Description and Business Overview
      • 6.13.3 Sinomune Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Sinomune Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.13.5 Sinomune Pharmaceutical Recent Developments/Updates
    • 6.14 Maoxiang Pharmacy
      • 6.14.1 Maoxiang Pharmacy Corporation Information
      • 6.14.2 Maoxiang Pharmacy Methotrexate Tablets Description and Business Overview
      • 6.14.3 Maoxiang Pharmacy Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Maoxiang Pharmacy Methotrexate Tablets Product Portfolio
      • 6.14.5 Maoxiang Pharmacy Recent Developments/Updates
    • 6.15 INE
      • 6.15.1 INE Corporation Information
      • 6.15.2 INE Methotrexate Tablets Description and Business Overview
      • 6.15.3 INE Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.15.4 INE Methotrexate Tablets Product Portfolio
      • 6.15.5 INE Recent Developments/Updates
    • 6.16 Zhengqing Pharmaceutical
      • 6.16.1 Zhengqing Pharmaceutical Corporation Information
      • 6.16.2 Zhengqing Pharmaceutical Methotrexate Tablets Description and Business Overview
      • 6.16.3 Zhengqing Pharmaceutical Methotrexate Tablets Sales, Revenue and Gross Margin (2017-2022)
      • 6.16.4 Zhengqing Pharmaceutical Methotrexate Tablets Product Portfolio
      • 6.16.5 Zhengqing Pharmaceutical Recent Developments/Updates

    7 Methotrexate Tablets Manufacturing Cost Analysis

    • 7.1 Methotrexate Tablets Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Methotrexate Tablets
    • 7.4 Methotrexate Tablets Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Methotrexate Tablets Distributors List
    • 8.3 Methotrexate Tablets Customers

    9 Methotrexate Tablets Market Dynamics

    • 9.1 Methotrexate Tablets Industry Trends
    • 9.2 Methotrexate Tablets Market Drivers
    • 9.3 Methotrexate Tablets Market Challenges
    • 9.4 Methotrexate Tablets Market Restraints

    10 Global Market Forecast

    • 10.1 Methotrexate Tablets Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Methotrexate Tablets by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Methotrexate Tablets by Type (2023-2028)
    • 10.2 Methotrexate Tablets Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Methotrexate Tablets by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Methotrexate Tablets by Application (2023-2028)
    • 10.3 Methotrexate Tablets Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Methotrexate Tablets by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Methotrexate Tablets by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      Industry Insights
      Due to the COVID-19 pandemic, the global Methotrexate Tablets market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Methotrexate Tablets market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Methotrexate Tablets landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      2mg accounting for % of the Methotrexate Tablets global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cancers segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of Methotrexate Tablets include Accord Healthcare, Cipla, Morningside Healthcare, Ebewe Pharma, Orion, Nihon Generic, Nippon Zoki Pharmaceutical, Daito Pharmaceutical and Nichi-Iko Pharmaceutical, etc. In terms of revenue, the global 3 largest players have a % market share of Methotrexate Tablets in 2021.
      This report focuses on Methotrexate Tablets volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Methotrexate Tablets market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the Methotrexate Tablets market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      2mg
      2.5mg
      10mg
      Others
      Segment by Application
      Cancers
      Rheumatoid Arthritis
      Others
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      Accord Healthcare
      Cipla
      Morningside Healthcare
      Ebewe Pharma
      Orion
      Nihon Generic
      Nippon Zoki Pharmaceutical
      Daito Pharmaceutical
      Nichi-Iko Pharmaceutical
      Towa Pharmaceutical
      Mitsubishi Tanabe Pharma
      Ayumi Pharmaceutical
      Sinomune Pharmaceutical
      Maoxiang Pharmacy
      INE
      Zhengqing Pharmaceutical
      Frequently Asked Questions
      Which product segment grabbed the largest share in the Methotrexate Tablets market?
      How is the competitive scenario of the Methotrexate Tablets market?
      Which are the key factors aiding the Methotrexate Tablets market growth?
      Which are the prominent players in the Methotrexate Tablets market?
      Which region holds the maximum share in the Methotrexate Tablets market?
      What will be the CAGR of the Methotrexate Tablets market during the forecast period?
      Which application segment emerged as the leading segment in the Methotrexate Tablets market?
      What key trends are likely to emerge in the Methotrexate Tablets market in the coming years?
      What will be the Methotrexate Tablets market size by 2028?
      Which company held the largest share in the Methotrexate Tablets market?


      Summary:
      Get latest Market Research Reports on Methotrexate Tablets. Industry analysis & Market Report on Methotrexate Tablets is a syndicated market report, published as Global Methotrexate Tablets Market Research Report 2022. It is complete Research Study and Industry Analysis of Methotrexate Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,343.20
      4,686.40
      2,763.70
      5,527.40
      372,418.00
      744,836.00
      225,011.00
      450,022.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report